The remaining two cases developed in FDRs, one belonging to a family with a truncating variant in MSH2 and this individual’s tumor had retained MSH2 expression but was MSI-L/MSI-H when analyzed by the Promega assay. The gene discussed is MSH2; the disease is neoplasm.